Show simple item record

AuthorRayyan, Yaser Mohammed
AuthorAgraib, Lana M.
AuthorAlkhatib, Buthaina
AuthorYamani, Mohammed I.
AuthorAbu-Sneineh, Awni Taleb
AuthorTayyem, Reema F.
Available date2023-11-14T16:28:01Z
Publication Date2023-10-01
Publication NameEuropean Journal of Nutrition
Identifierhttp://dx.doi.org/10.1007/s00394-023-03207-8
CitationRayyan, Y. M., Agraib, L. M., Alkhatib, B., Yamani, M. I., Abu-Sneineh, A. T., & Tayyem, R. F. (2023). Does probiotic supplementation improve quality of life in mild-to-moderately active ulcerative colitis patients in Jordan? A secondary outcome of the randomized, double-blind, placebo-controlled study. European Journal of Nutrition, 62(7), 3069-3077.‏
ISSN14366207
URIhttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85165870446&origin=inward
URIhttp://hdl.handle.net/10576/49262
AbstractPurpose: Recent findings revealed a potential effect of a probiotic in improving quality of life (QoL) in ulcerative colitis (UC). In Jordan, there is scarce data about UC patients and QoL. Methods: Twenty-four UC patients were included in the study and were randomly allocated into probiotic (3 × 1010 probiotic capsules containing nine Lactobacillus and five Bifidobacterium species) and placebo control groups (containing polysaccharide supplied in an identical bottle) 3 times daily/6 weeks. A short inflammatory bowel disease questionnaire (SIBDQ) was used to assess the change in the quality of life in both groups at the beginning and the end of the intervention; The study was completed during the COVID-19 pandemic. Results: Patients treated with probiotics showed a higher score of social (6.92 ± 0.29, p = 0.019), bowel (6.31 ± 0.46, p = 0.001), emotional (6.47 ± 0.46, p < 0.001), and total SIBDQ scores (6.54 ± 0.29, p < 0.001) compared to the placebo group (5.75 ± 1.57, 4.72 ± 1.34, 4.42 ± 1.67 and 4.96 ± 1.27; respectively). Also, the probiotic group had significantly better scores in the systemic, social, bowel, emotional, and total SIBDQ scores in terms of pre- to post-treatment (p < 0.001). Conclusions: The use of probiotic therapy containing Lactobacillus and Bifidobacterium species had significantly improved the quality of life among UC patients, this was shown by the improvement in the scores of the systemic domain, social domain, bowel domain, emotional domain, and total SIBDQ. This study is part of a registered study at ClinicalTrials.gov with the number NCT04223479.
Languageen
Publisherspringer link
SubjectMild to moderate disease activity
Probiotics
Quality of life
Randomized clinical trial
Ulcerative colitis
TitleDoes probiotic supplementation improve quality of life in mild-to-moderately active ulcerative colitis patients in Jordan? A secondary outcome of the randomized, double-blind, placebo-controlled study
TypeArticle
Pagination3069-3077
Issue Number7
Volume Number62
dc.accessType Abstract Only


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record